An Open-label Trial to Evaluate the Safety and Efficacy of Chloral Hydrate in Patients With Severe Insomnia
Status:
Recruiting
Trial end date:
2023-12-01
Target enrollment:
Participant gender:
Summary
The primary aim of this Real-World Evidence trial is to establish whether short-term (2
weeks) treatment of Chloral Hydrate is effective in patients with severe insomnia which is
interfering with normal daily life, and where other behavioural and pharmacologic therapies
have failed in a real world setting.